<Disease><Name>MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)</Name><Synonym>ALPERS-HUTTENLOCHER SYNDROME</Synonym><OMIM><Number>203700</Number><URL>http://omim.org/entry/203700</URL></OMIM><Orphanet><Number>726</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=726</URL></Orphanet><Protein><Number>DNA polymerase subunit gamma-1 (POLG)</Number><URL>http://www.uniprot.org/uniprot/P54098</URL></Protein><ExPASy><Number>2.7.7.7</Number><URL>http://enzyme.expasy.org/EC/2.7.7.7</URL></ExPASy><Gene>15q26.1</Gene><ICD>G31.88</ICD><Summary>rare ;autosomal recessive ;severe developmental delay, intractable seizures and liver involvement in a previously healthy child (Gauthier-Villars M et al. 2001)</Summary><Symptoms><symtomp><id>2470</id><symptom>areflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1698</id><symptom>fetal akinesia/hypokinesia sequence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3197</id><symptom>lactic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2380</id><symptom>liver failure</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2479</id><symptom>MRS, brain, abnormalities / Magnetic resonance spectroscopy (MRS)</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3967</id><symptom>status epilepticus</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1576</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>3.40</min><max>9.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1615</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.20</min><max>5.80</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1709</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>17.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1808</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>20.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>83</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1342</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1343</id><name>3-Methylglutaconic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1156</id><name>3-Methylglutaconic acid</name><specimen>amnion fluid</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>445</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>614</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>615</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>616</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>617</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>618</id><name>Ethylmalonic acid</name><specimen>urine</specimen><value>normal/inc</value><min>2.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>767</id><name>L-Lactic acid</name><specimen>jejunal biopsy</specimen><value>normal/inc</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>21</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>3.50</min><max>29.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>536</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>197.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>537</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>40.00</min><max>326.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>538</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>5.00</min><max>117.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>539</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>6.00</min><max>64.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1411</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>100.00</min><max>152.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>330</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>3.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>339</id><name>L-Lactic acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.50</min><max>1.80</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>469</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>208</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>211</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>214</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>1.00</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>206</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>2.00</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>209</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.50</min><max>1.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>212</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.60</min><max>0.90</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>202</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.80</min><max>1.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>210</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>213</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.40</min><max>1.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1137</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.40</min><max>0.90</max><unit>mmol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>1136</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.70</min><max>1.60</max><unit>mmol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>203</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>0.90</min><max>1.80</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>204</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>1.00</min><max>1.50</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>207</id><name>L-Lactic acid</name><specimen>blood</specimen><value>normal/inc</value><min>2.00</min><max>3.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1813</id><name>L-Lactic acid</name><specimen>urine</specimen><value>normal/inc</value><min>45.00</min><max>410.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>766</id><name>Protein, total</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5402</id><title>Understanding the Epilepsy in POLG Related Disease</title><author>Hikmat O,</author><journal>Int J Mol Sci</journal><year>2017</year><book /><volume>18</volume><number>9</number><pages>E1845</pages><co_aut>et al.</co_aut></literature><literature><id>3527</id><title>A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.</title><author>Rajakulendran S,</author><journal>PLoS One</journal><year>2016</year><book /><volume>11</volume><number>1</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5945</id><title>Alpers-Huttenlocher syndrome: the role of a multidisciplinary health care team</title><author>Saneto RP</author><journal>J Multidiscip Healthc</journal><year>2016</year><book /><volume>9</volume><number>0</number><pages>323-333</pages><co_aut /></literature><literature><id>3528</id><title>Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-d</title><author>Li S,</author><journal>Hepatology</journal><year>2015</year><book /><volume>61</volume><number>5</number><pages>1730-1739</pages><co_aut>et al.</co_aut></literature><literature><id>3529</id><title>Alpers disease mutations in human DNA polymerase gamma cause catalytic defects in mitochondrial DNA replication by distinct mechanisms</title><author>Qian Y,</author><journal>Front Genet</journal><year>2015</year><book /><volume>6</volume><number>0</number><pages>135</pages><co_aut>Ziehr JL, Johnson KA</co_aut></literature><literature><id>3530</id><title>Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrom</title><author>Sofou K,</author><journal>Mol Genet Genomic Med</journal><year>2015</year><book /><volume>3</volume><number>1</number><pages>59-68</pages><co_aut>et al.</co_aut></literature><literature><id>3531</id><title>The in cis T251I and P587L POLG1 base changes: description of a new family and literature review</title><author>Scuderi C,</author><journal>Neuromuscul Disord</journal><year>2015</year><book /><volume>25</volume><number>4</number><pages>333-339</pages><co_aut>et al.</co_aut></literature><literature><id>5407</id><title>POLG-Related Disorders</title><author>Cohen BH,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2014</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5946</id><title>Alpers-Huttenlocher syndrome</title><author>Saneto RP,</author><journal>Pediatr Neurol</journal><year>2013</year><book /><volume>48</volume><number>3</number><pages>167-178</pages><co_aut>et al.</co_aut></literature><literature><id>2877</id><title>De novo mutation in POLG leads to haplotype insufficiency and Alpers syndrome</title><author>Chan SS</author><journal>Mitochondrion</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2878</id><title>Ketogenic diet in Alpers-Huttenlocher syndrome</title><author>Joshi CN</author><journal>Pediatr Neurol</journal><year>2009</year><book /><volume>40</volume><number>4</number><pages>314-316</pages><co_aut>et al.</co_aut></literature><literature><id>2308</id><title>POLG mutations and Alpers syndrome</title><author>Davidzon G</author><journal>Ann Neurol</journal><year>2005</year><book /><volume>57</volume><number>6</number><pages>921-923</pages><co_aut>et al.</co_aut></literature><literature><id>1608</id><title>Late Onset of Treatment with a Chemokine Receptor CCR1 Antagonist Prevents Progression of Lupus Nephritis in MRL-Fas(lpr) Mice&lt;</title><author>Anders HJ</author><journal>J Am Soc Nephrol</journal><year>2004</year><book /><volume>15</volume><number>6</number><pages>1504-1513</pages><co_aut>et al.</co_aut></literature><literature><id>1609</id><title>POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion</title><author>Naviaux RK</author><journal>Ann Neurol</journal><year>2004</year><book /><volume>55</volume><number>5</number><pages>706-712</pages><co_aut>Nguyen KV</co_aut></literature><literature><id>1610</id><title>Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease</title><author>Simonati A</author><journal>J Neurol</journal><year>2003</year><book /><volume>250</volume><number>6</number><pages>702-706</pages><co_aut>et al.</co_aut></literature><literature><id>1180</id><title>Respiratory chain deficiency in Alpers syndrome</title><author>Gauthier-Villars M</author><journal>Neuropediatrics</journal><year>2001</year><book /><volume>32</volume><number>0</number><pages>150-152</pages><co_aut>et al.</co_aut></literature><literature><id>1424</id><title>Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease</title><author>Rasmussen M</author><journal>J Child Neurol</journal><year>2000</year><book /><volume>15</volume><number>7</number><pages>473-477</pages><co_aut>et al.</co_aut></literature><literature><id>95</id><title>Oxidative phosphorylation diseases</title><author>Shoffner JM</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>46</number><pages>1535-1609</pages><co_aut>Wallace DC</co_aut></literature><literature><id>474</id><title>Progressive neuronal degeneration of childhood with liver disease (Alpers disease) presenting in young adults</title><author>Harding BN</author><journal>J Neurol Neurosurg Psychiatry</journal><year>1995</year><book /><volume>58</volume><number>3</number><pages>320-325</pages><co_aut>et al.</co_aut></literature><literature><id>605</id><title>Alpers syndrome presenting with seizures and multiple stroke-like episodes in a 17-year-old male</title><author>Montine TJ</author><journal>Clin Neuropathol</journal><year>1995</year><book /><volume>14</volume><number>0</number><pages>322-326</pages><co_aut>et al.</co_aut></literature><literature><id>475</id><title>[Progressive neuronal degeneration of childhood with liver disease (Morbus Alpers)]</title><author>Moeller P</author><journal>Monatschr Kinderheilk</journal><year>1994</year><book /><volume>142</volume><number>0</number><pages>863-867</pages><co_aut>et al.</co_aut></literature><literature><id>472</id><title>Progressive neuronal degeneration of childhood (Alpers syndrome) with hepatic cirrhosis</title><author>Wilson DC</author><journal>Eur J Pediatr</journal><year>1993</year><book /><volume>152</volume><number>3</number><pages>260-262</pages><co_aut>et al.</co_aut></literature><literature><id>473</id><title>Alpers progressive infantile neuronal poliodystrophy: an acute neonatal form with findings of the fetal akinesia syndrome</title><author>Frydman M</author><journal>Am J Med Genet</journal><year>1993</year><book /><volume>47</volume><number>1</number><pages>31-36</pages><co_aut>et al.</co_aut></literature><literature><id>917</id><title>Liver involvement in Alpers disease</title><author>Narkewicz MR</author><journal>J Pediatr</journal><year>1991</year><book /><volume>119</volume><number>0</number><pages>260-267</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>